肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

子宫颈癌免疫预防转诊策略

2021-11-03 长三角宫颈癌及女性下生殖道感染防控联盟 肿瘤综合治疗电子杂志

妇科肿瘤子宫颈癌

在中国，子宫颈癌已成为严重威胁女性健康的公共卫生问题。为响应世界卫生组织于2020年启动的《加速消除子宫颈癌全球战略》，本文系统整理了国内外关于子宫颈癌综合防控经验，探索了子宫颈癌免疫预防转诊策略。

中文标题：

子宫颈癌免疫预防转诊策略

英文标题：

Referral strategy on immunological prevention of cervical cancer

发布机构：

长三角宫颈癌及女性下生殖道感染防控联盟

发布日期：

2021-11-03

简要介绍：

在中国，子宫颈癌已成为严重威胁女性健康的公共卫生问题。为响应世界卫生组织于2020年启动的《加速消除子宫颈癌全球战略》，本文系统整理了国内外关于子宫颈癌综合防控经验，探索了子宫颈癌免疫预防转诊策略。通过建立临床医疗机构与疾控机构之间的沟通交流机制，以期打通有效运行的子宫颈癌三级预防策略，从而惠及更多的女性。

相关资料下载：
[AttachmentFileName(sort=1, fileName=子宫颈癌免疫预防转诊策略.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9e5e71c002255351, title=子宫颈癌免疫预防转诊策略, enTitle=Referral strategy on immunological prevention of cervical cancer, guiderFrom=肿瘤综合治疗电子杂志, authorId=0, author=, summary=在中国，子宫颈癌已成为严重威胁女性健康的公共卫生问题。为响应世界卫生组织于2020年启动的《加速消除子宫颈癌全球战略》，本文系统整理了国内外关于子宫颈癌综合防控经验，探索了子宫颈癌免疫预防转诊策略。, cover=https://img.medsci.cn/2021114/1636037835715_5579292.jpg, journalId=0, articlesId=null, associationId=2105, associationName=长三角宫颈癌及女性下生殖道感染防控联盟, associationIntro=长三角宫颈癌及女性下生殖道感染防控联盟, copyright=0, guiderPublishedTime=Wed Nov 03 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">在中国，子宫颈癌已成为严重威胁女性健康的公共卫生问题。为响应世界卫生组织于2020年启动的《加速消除子</span><span style="color: #373737;">宫颈癌全球战略》，本文系统整理了国内外关于子宫颈癌综合防控经验，探索了子宫颈癌免疫预防转诊策略。通过建立临床</span><span style="color: #373737;">医疗机构与疾控机构之间的沟通交流机制，以期打通有效运行的子宫颈癌三级预防策略，从而惠及更多的女性。</span></p>, tagList=[TagDto(tagId=1983, tagName=妇科肿瘤), TagDto(tagId=18201, tagName=子宫颈癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21053, categoryName=梅斯医学-宫颈癌网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=18201, guiderKeyword=子宫颈癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7180, appHits=93, showAppHits=0, pcHits=292, showPcHits=7086, likes=0, shares=40, comments=8, approvalStatus=1, publishedTime=Tue Nov 16 23:56:36 CST 2021, publishedTimeString=2021-11-03, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Fri Nov 05 10:48:01 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Tue Jan 02 15:39:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=子宫颈癌免疫预防转诊策略.pdf)])
子宫颈癌免疫预防转诊策略.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1079237, encodeId=394410e9237c3, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd796394025, createdName=ms5000000312608765, createdTime=Sun Dec 12 12:26:39 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077676, encodeId=357010e76768b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a34c5388873, createdName=ms8000000712544130, createdTime=Tue Dec 07 10:08:26 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075734, encodeId=5e2510e573408, content=免疫治疗还有点远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Wed Dec 01 08:30:10 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070185, encodeId=569b10e018565, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 14 16:32:05 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069662, encodeId=641e1069662a8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211112/9a1e2f3fd5e54b9983a20b6a4f6e0c53/63a68926d9d54e6fafa6b5674a146ce4.jpg, createdBy=c3365708000, createdName=ms2000000805773481, createdTime=Fri Nov 12 15:34:12 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2021-12-12 ms5000000312608765

    不错👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1079237, encodeId=394410e9237c3, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd796394025, createdName=ms5000000312608765, createdTime=Sun Dec 12 12:26:39 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077676, encodeId=357010e76768b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a34c5388873, createdName=ms8000000712544130, createdTime=Tue Dec 07 10:08:26 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075734, encodeId=5e2510e573408, content=免疫治疗还有点远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Wed Dec 01 08:30:10 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070185, encodeId=569b10e018565, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 14 16:32:05 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069662, encodeId=641e1069662a8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211112/9a1e2f3fd5e54b9983a20b6a4f6e0c53/63a68926d9d54e6fafa6b5674a146ce4.jpg, createdBy=c3365708000, createdName=ms2000000805773481, createdTime=Fri Nov 12 15:34:12 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2021-12-07 ms8000000712544130

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1079237, encodeId=394410e9237c3, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd796394025, createdName=ms5000000312608765, createdTime=Sun Dec 12 12:26:39 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077676, encodeId=357010e76768b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a34c5388873, createdName=ms8000000712544130, createdTime=Tue Dec 07 10:08:26 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075734, encodeId=5e2510e573408, content=免疫治疗还有点远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Wed Dec 01 08:30:10 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070185, encodeId=569b10e018565, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 14 16:32:05 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069662, encodeId=641e1069662a8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211112/9a1e2f3fd5e54b9983a20b6a4f6e0c53/63a68926d9d54e6fafa6b5674a146ce4.jpg, createdBy=c3365708000, createdName=ms2000000805773481, createdTime=Fri Nov 12 15:34:12 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2021-12-01 1e167f5cm82(暂无匿称)

    免疫治疗还有点远

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1079237, encodeId=394410e9237c3, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd796394025, createdName=ms5000000312608765, createdTime=Sun Dec 12 12:26:39 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077676, encodeId=357010e76768b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a34c5388873, createdName=ms8000000712544130, createdTime=Tue Dec 07 10:08:26 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075734, encodeId=5e2510e573408, content=免疫治疗还有点远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Wed Dec 01 08:30:10 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070185, encodeId=569b10e018565, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 14 16:32:05 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069662, encodeId=641e1069662a8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211112/9a1e2f3fd5e54b9983a20b6a4f6e0c53/63a68926d9d54e6fafa6b5674a146ce4.jpg, createdBy=c3365708000, createdName=ms2000000805773481, createdTime=Fri Nov 12 15:34:12 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2021-11-14 ms3000001592172450

    受益匪浅！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1079237, encodeId=394410e9237c3, content=不错👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dd796394025, createdName=ms5000000312608765, createdTime=Sun Dec 12 12:26:39 CST 2021, time=2021-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077676, encodeId=357010e76768b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a34c5388873, createdName=ms8000000712544130, createdTime=Tue Dec 07 10:08:26 CST 2021, time=2021-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1075734, encodeId=5e2510e573408, content=免疫治疗还有点远, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad431973539, createdName=1e167f5cm82(暂无匿称), createdTime=Wed Dec 01 08:30:10 CST 2021, time=2021-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070185, encodeId=569b10e018565, content=受益匪浅！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee335603873, createdName=ms3000001592172450, createdTime=Sun Nov 14 16:32:05 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069662, encodeId=641e1069662a8, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211112/9a1e2f3fd5e54b9983a20b6a4f6e0c53/63a68926d9d54e6fafa6b5674a146ce4.jpg, createdBy=c3365708000, createdName=ms2000000805773481, createdTime=Fri Nov 12 15:34:12 CST 2021, time=2021-11-12, status=1, ipAttribution=)]
    2021-11-12 ms2000000805773481

    好

    0

相关指南

妇科肿瘤铂类药物临床应用指南

中华医学会妇科肿瘤学分会 · 2021-09-18

妇科肿瘤治疗后下肢淋巴水肿专家共识

妇产科相关专家组（统称） · 2020-02-01

遗传性妇科肿瘤高风险人群管理专家共识（2020）

中国抗癌协会(Chinese Anti-cancer Association) · 2020-09-03

2020 SGO临床实践声明：激素治疗（HT）在妇科肿瘤以及妇科肿瘤高危女性中的应用

美国妇科肿瘤学会(SGO,Society of Gynecologic Oncology) · 2020-02-14

妇科肿瘤抗血管内皮生长因子单克隆抗体临床应用指南

中华医学会妇科肿瘤学分会 · 2020-01-20

2019 曼彻斯特国际共识组建议：林奇综合征妇科肿瘤的管理

国外肿瘤科相关专家小组（统称） · 2019-03-28

拓展阅读

中国子宫颈癌筛查及异常管理相关问题专家共识（二）

暂未更新 · 2017-05-30

中国子宫颈癌综合防控指南

中华预防医学会(CPMA,Chinese Preventive Medicine Association) 妇女保健分会 · 2018-01-30

阴道上皮内瘤变诊治专家共识（2020）

暂未更新 · 2020-08-10

子宫颈癌腹腔镜手术治疗的中国专家共识

中国肿瘤科相关专家小组（统称） · 2020-09-30

2020 EANM/SNMMI实践指南：子宫颈癌18 F-FDG PET/CT 外照射放射治疗方案

欧洲核医学协会(EANM,European Association of Nuclear Medicine) · 2020-12-04

新型冠状病毒肺炎疫情防控期间子宫颈癌三级防控综合管理中国专家共识

中国医师协会妇产科医师分会 · 2021-02-15